Studies by Lucchesi et al. [3] recently demonstrated that while the wild-type form of ECRG2 exhibited strong growth suppression in cancer cells, the tumor-derived ECRG2 V30E mutant (identified in human lung cancer) failed to inhibit cancer cell growth. This evidence concerns the gene SPINK7 and lung carcinoma.